Trial Site Detail

 

Drug:
DCC-3116 + Ripretinib
Trial:
A Study of DCC-3116 in Combination with Anticancer Therapies in Participants with Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

University of Massachusetts Worcester

55 Lake Ave.     
Worcester , MA 01655
USA

 

Principal Investigator:
 Matthew Hemming, MD, PhD
Contact:
 Syliva Rollins 7744554454 Sylvia.Rollins@umassmed.edu
Activation Status of this Site:
 Active
Notes about this Site:
University of Massachusetts Worcester Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.